Surrozen

SRZNNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$517.446 M

$29.07 -8.15%

Close of 6 Nov 2026

As of 6 Nov 2026, Surrozen (SRZN) has a market capitalization of $517.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.48M

#3320 by revenue

Earnings

-$242.0M

Loss-making

Shares outstanding

11,753,558

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#62Valneva SEVALN$532.9M
#63Entera BioENTX$521.8M
#64SurrozenSRZN$517.4M
#65SL ScienceSLBT$504.7M
#66RegenxbioRGNX$487.2M

What if Surrozen were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,586,341

Per share 54,570× higher

Bitcoin $1.53T

$85,834.16

Per share 2,953× higher

Apple $5.02T

$281,785.54

Per share 9,693× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Surrozen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.